Pancreatic abnormalities in patients with eating disorders

Area of Science:

• Gastroenterology
• Endocrinology
• Nutritional Science

Background:

• Eating disorders like anorexia nervosa and bulimia can impact various bodily systems.
• Pancreatic function is crucial for digestion and metabolic regulation.
• Previous research has explored endocrine and metabolic disturbances in eating disorders.

Purpose of the Study:

• To investigate potential pancreatic abnormalities in patients with eating disorders.
• To assess serum elastase 1 levels and glucose tolerance in different eating disorder subgroups.
• To explore the relationship between pancreatic markers and endocrine responses.

Main Methods:

• Serum elastase 1 levels were measured using radioimmunoassay (RIA).
• A 50g oral glucose tolerance test (OGTT) was administered.
• Patients were categorized into anorexia nervosa with bulimia (AN-B), anorexia nervosa restrictive (AN-R), and bulimia (B) groups.
• Serum elastase 1 was measured on admission and after weight gain in anorectic patients.

Main Results:

• Serum elastase 1 levels were significantly higher in AN-B and AN-R groups compared to the bulimia group and healthy controls.
• A significant decrease in serum elastase 1 was observed after body weight gain in anorectic patients.
• No significant correlation was found between serum elastase 1 levels and insulin response during the OGTT.

Conclusions:

• Elevated serum elastase 1 in anorexia nervosa suggests pancreatic abnormalities.
• These pancreatic abnormalities appear distinct from endocrinological events.
• Further research is needed to elucidate the specific nature of pancreatic dysfunction in eating disorders.